Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Neoki Pharma AB
AB
Active
Org 5590812706
Berthåga Byväg 14 A, 752 60
Uppsala
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2016
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Neoki Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
1M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
1M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
253
783
495
414
Staff expenses
—
—
−0
−0
−0
EBITDA
−15
230
760
467
394
Depreciation & amort.
−0
−0
—
—
—
EBIT
−15
230
760
467
394
Net financials
−16
—
—
−0
−4
Profit before tax
−17
231
760
524
290
Tax
−0
−48
−157
−112
−62
Net profit
−17
183
603
412
228
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
893
1 181
2 074
1 926
2 151
Equity
647
830
1 233
1 445
1 673
Long-term debt
7
7
8
8
8
Short-term debt
0
106
595
292
189
Total debt
7
113
603
300
197
Financial ratios
5-year trend
EBITDA margin
95.1%
This company
15.8%
Market median
+502% vs market
2020
2024
Equity ratio
77.8%
This company
38.2%
Market median
+104% vs market
2020
2024
Return on equity
13.6%
This company
18.4%
Market median
+26% vs market
2020
2024
Net profit margin
55.1%
This company
8.1%
Market median
+580% vs market
2020
2024
Asset turnover
0.19×
This company
1.12×
Market median
-83% vs market
2020
2024
Debt / equity
0.29×
This company
0.62×
Market median
+53% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Neoki Pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
